Results 181 to 190 of about 3,697,166 (278)

A Remote Program for Navigator‐ and Pharmacist‐Led Management of Obesity Medications in Adults: Rationale, Design, and Implementation

Obesity Science &Practice, Volume 12, Issue 4, August 2026.
ABSTRACT Objective Remote interventions leveraging team‐based care may ameliorate persistent gaps in obesity medication implementation, but prospective studies are lacking. In this paper, the design, enrollment, and implementation of a remote intervention for obesity medications are described.
Bryn Falahee, John W. Ostrominski, Kavishwar B. Wagholikar, Ozan Unlu, David Zelle, Sanjay Kumar, Daniel Gabovitch, Michela Tucci, Austen Smith, Hunter Nichols, Irene G. McCarthy, Samar Mushtaque, Tabitha V. Rutkowski, Ashley C. McCarthy, Heather J. Baer, Christopher P. Cannon, Naomi D. L. Fisher, Jorge Plutzky, Caroline M. Apovian, Benjamin M. Scirica, Alexander J. Blood   +20 more
wiley   +1 more source

Progress in the Treatment of Ulcerative Colitis by Targeting NLRP3 Inflammasome. [PDF]

Drug Des Devel Ther
Chen J, Zhang E, Qian X, Shang X, Yu J, Luo J, Hao W.   +6 more
europepmc   +1 more source

Peri‐operative management of diabetes mellitus: a multidisciplinary consensus statement from the Association of Anaesthetists and the Joint British Diabetes Societies for Inpatient Care group

Anaesthesia, Volume 81, Issue 8, Page 1116-1131, August 2026.
Summary Introduction Surgery in patients with diabetes mellitus is associated with increased morbidity and mortality compared with those who do not have diabetes mellitus. This is likely multifactorial and could be attributed to organisational issues; dysglycaemia; hospital‐acquired diabetic ketoacidosis; errors with insulin prescribing and ...
Nicholas A. Levy, Kariem El‐Boghdadly, Dileep N. Lobo, Daniel J. Stubbs, Parizad Avari, Donal Buggy, Claire Frank, Kim Howson, Jinty Moffett, Emma Morris, Omar G. Mustafa, Glynn Nash, Pádraig Ó Scanaill, Sarah Procter, Gerry Rayman, Kim Russon, Caroline Thomas, Sarah Tinsley, Allan Xu, Ketan Dhatariya   +19 more
wiley   +1 more source

Herbicides in Use: Current Status and Perspectives in the Different Biogeographic Regions of Europe. [PDF]

J Agric Food Chem
Synowiec A, Czekaj M, Verdeguer M, De Barreda DG, Campillo-Cora C, Vieites-Álvarez Y, López-González D, Sánchez-Moreiras AM, Fernández-Calviño D, Nocito FF, Ragonezi C, Almeida Pinheiro de Carvalho MA, Sutri M, Shanskiy M, Eddudóttir SD, Fedoniuk TP, Vityi A, Bürgener U, Piron L, Gidea M, Espinosa Escrig F, Beker Akbulut G, Morugán Coronado A, Valiño E, Araniti F.   +24 more
europepmc   +1 more source

Secular Trend in Glycaemic Management in Type 2 Diabetes Patients With and Without Cirrhosis Between 2000 and 2023: A Territory‐Wide Cohort Study

Alimentary Pharmacology &Therapeutics, Volume 64, Issue 3, Page 356-366, August 2026.
In this territory‐wide cohort study, improving glycemic control can be observed regardless of cirrhosis status. Oral antidiabetic medication was more often used in the non‐cirrhosis group, and insulin was preferred in patients with decompensated cirrhosis, who exhibited an increasing incidence of hypoglycemia over the years and need individualized ...
Mary Yue Wang, Sherlot Juan Song, Nana Peng, Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong, Jimmy Che‐To Lai, Terry Cheuk‐Fung Yip   +6 more
wiley   +1 more source

Transcriptome and physiological analysis of the response mechanism of Panax ginseng to Benazolin of sulfonylurea herbicide. [PDF]

Sci Rep
Yang H, Jin H, Dong X, Xu Y.
europepmc   +1 more source

Expert considerations to guide the development and delivery of an exercise intervention in people with type 2 diabetes‐related foot ulcer disease

Diabetic Medicine, Volume 43, Issue 8, August 2026.
Abstract Objective Engaging in exercise presents unique challenges for those with type 2 diabetes (T2D) and diabetes‐related foot ulcer disease (DFUD). This brief report describes the development of practical considerations aiming to support exercise in people with T2D and DFUD.
Vicki L. Johnson, Vicky Hall, Rachel Berrington, Julia Burdon, Sally Schreder, Matthew McCarthy, Chris Brough, Patrick J. Highton, Michelle Hadjiconstantinou, Frances L. Game, Lisa J. Keogh, Solomon Tesfaye, Jonathan Valabhji, John R. Petrie, Ketan K. Dhatariya, Tom Yates, Melanie J. Davies, Kamlesh Khunti   +17 more
wiley   +1 more source

Exploring Combined Use of Continuous Glucose Monitoring and Anti-Diabetes Medications on Glycaemic Control for People With Type 2 Diabetes Not Using Insulin. [PDF]

Endocrinol Diabetes Metab
Nemlekar PM, Hannah KL, Green CR, Norman GJ.   +3 more
europepmc   +1 more source

Real-World Harm Reduction of Metformin Plus DPP4 Inhibitors versus Metformin Plus Sulfonylureas in Older Adults: A Target Trial Emulation Using German Claims Data. [PDF]

Drugs Aging
Starke P, Thürmann P, Grobe T, Friede T, Mathes T.   +4 more
europepmc   +1 more source

Association Between SGLT2 Inhibitors and DPP‐4 Inhibitors Use and Risk of Acute Pancreatitis: Findings From Nationwide Case‐Based Analyses

Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 6767-6775, August 2026.
ABSTRACT Aims The Korean national health insurance claims database was utilised to investigate the association between sodium–glucose cotransporter 2 inhibitors (SGLT2i) or dipeptidyl peptidase‐4 inhibitors (DPP‐4i) and the risk of acute pancreatitis (AP). Materials and Methods Patients with type 2 diabetes mellitus prescribed DPP‐4i or SGLT2i at least
Ye‐Jee Kim, Yun Kyung Cho, Mi‐Sook Kim, Joongyub Lee, Seonghae Kim, Bo Ram Yang   +5 more
wiley   +1 more source